C3-BINDING AGENTS AND METHODS OF USE THEREOF
The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
La présente invention concerne des agents de liaison, tels que des anticorps (y compris des fragments variables à chaîne unique), qui se lient de manière spécifique à la composante C3 du complément, notamment C3 humaine, des compositions les comprenant, et des procédés d'utilisation associés. L'invention concerne également des polynucléotides et des vecteurs associés codant pour les agents de liaison et des cellules les comprenant. |
---|---|
Bibliography: | Application Number: CA20193093356 |